Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control
- PMID: 11887162
- DOI: 10.1053/meta.2002.30502
Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control
Abstract
Although obesity is a frequent feature of type 2 diabetes mellitus (DM), many patients with type 1 DM are prone to high body mass index (BMI). We measured serum leptin concentrations in a cohort of children (n = 55) with type 1 diabetes mellitus (DM), as well as their anthropometric parameters including BMI, skin fold thickness at multiple sites, and midarm circumference. Glycemic control was assessed by blood glucose (BG) monitoring before meals, and measurement of glycated hemoglobin (HbA1c) and insulin dose/kg/d was recorded. Dietary evaluation and assessment of caloric intake (kg/d) was performed by an expert dietitian. In the newly diagnosed children (n = 10) before initiation of insulin therapy, circulating leptin concentration was significantly lower (1.1 +/- 0.8 ng/dL) versus 5 days after insulin therapy (1.45 +/- 0.7 ng/dL). The decreased leptin level appears to be related to insulinopenia in these patients. In 45 children with type 1 DM on conventional therapy (2 doses of insulin mixture (NPH and regular) subcutaneous (SC) before breakfast and dinner for more than 2 years), serum leptin concentration was significantly higher (2.15 +/- 1 ng/dL) compared with age-matched normal children (1.3 +/- 1 ng/dL). Diabetic children were further divided into 2 groups according to their HbA1c level: group 1 with HbA1C less than 7.5% (less than 2 SD above the mean for normal population) (n = 29) and group 2 with HbA1c greater than 7.5%. (greater than 2 SD above the mean for normal population) (n = 16). Patients with a higher HbA1c level (group 2) had a higher leptin concentration (2.3 +/- 0.8 ng/dL), higher BMI (17.8 +/- 1.7), and were receiving higher insulin dose/kg (0.92 +/- 0.2 U/kg/d) compared with group 1 (lower HbA1c) (1.78 +/- 0.8 ng/dL, 16.7 +/- 1.5, and 0.59 +/- 0.2 U/kg/d, respectively). Group 2 patients had a higher incidence of late morning hypoglycemia (9/29) versus group 1 patients (2/16). Analysis of dietary intake showed that patients with a higher HbA1c (group 2) consumed more calories (73.5 +/- 10.5 kcal/kg/d) versus patients with lower HbA1c (64.2 +/- 8.7 kcal/kg/d). These findings pointed to the unphysiologic nature of injecting a mixture of insulin twice daily. To cover the relatively big lunch meal (40% to 50% of the total caloric intake in the Arab countries) and prevent afternoon hyperglycemia, there is a great tendency to increase NPH dose before breakfast. This, in turn, induces late-morning hypoglycemia and increases appetite and food intake at that time. Multiple regression analysis showed that circulating leptin concentrations (the dependent variable) were best correlated with the mean skinfold thickness (SFT), BMI, and caloric intake/kg/d (together they explained 65% of the variability in leptin concentrations). It appears that oversubstitution by insulin and increased food intake stimulate fat synthesis and subsequently BMI. Increased appetite and BMI contribute to increased leptin secretion and explains the higher leptin levels in undercontrolled diabetic children (higher circulating HbA1c concentrations) who were oversubstituted by insulin.
Copyright 2002 by W.B. Saunders Company
Similar articles
-
Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index.Eur J Endocrinol. 1998 May;138(5):501-9. doi: 10.1530/eje.0.1380501. Eur J Endocrinol. 1998. PMID: 9625360
-
Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.Pediatrics. 2005 May;115(5):1320-4. doi: 10.1542/peds.2004-1439. Pediatrics. 2005. PMID: 15867042 Clinical Trial.
-
Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus.Diabetes Technol Ther. 2003;5(2):167-73. doi: 10.1089/152091503321827821. Diabetes Technol Ther. 2003. PMID: 12871606
-
Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes.Nutrients. 2018 Jan 22;10(1):109. doi: 10.3390/nu10010109. Nutrients. 2018. PMID: 29361766 Free PMC article. Review.
-
[Insulin therapy in type 1 diabetes for and during pregnancy: by which means and for which objectives?].Diabetes Metab. 2001 Sep;27(4 Pt 2):S61-6. Diabetes Metab. 2001. PMID: 11787439 Review. French.
Cited by
-
Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes.Pediatr Diabetes. 2016 May;17(3):184-90. doi: 10.1111/pedi.12255. Epub 2015 Jan 21. Pediatr Diabetes. 2016. PMID: 25611822 Free PMC article.
-
Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.Mol Cell Biochem. 2005 Jul;275(1-2):143-51. doi: 10.1007/s11010-005-1204-7. Mol Cell Biochem. 2005. PMID: 16335794
-
Bioleptin as a useful marker of metabolic status in children with diabetes mellitus type 1.Front Endocrinol (Lausanne). 2023 Aug 21;14:1235409. doi: 10.3389/fendo.2023.1235409. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37670877 Free PMC article.
-
Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse.J Physiol. 2017 Jul 1;595(13):4227-4243. doi: 10.1113/JP274030. Epub 2017 May 23. J Physiol. 2017. PMID: 28374413 Free PMC article.
-
Relationship of adiponectin and leptin with autoimmunity in children with new-onset type 1 diabetes: a pilot study.Pediatr Diabetes. 2016 Jun;17(4):249-56. doi: 10.1111/pedi.12267. Epub 2015 Mar 5. Pediatr Diabetes. 2016. PMID: 25754190 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical